About Namrata Sen Chanda
Namrata is an accomplished financial journalist, with nearly a decade of experience. She specializes in interpreting news releases and framing investment strategies, and has worked with some of the leading companies in real estate, banking, insurance, mutual funds, financial research, fintech, and investment education.
After majoring in finance at college, she became a research analyst, tracking economic indicators and analyzing major global economic developments. She then went on to become a contributing author for the Market Realist, focusing on the technology sector.
Namrata has a keen interest in fundamental analysis and is passionate about educating investors about the stock market.
Recent Articles By Namrata Sen Chanda
Forget Apple, Buy These 4 Faster-Growing Tech Stocks Instead
While Apple (AAPL) has been a favorite for investors, the stock could see a slowdown due to several factors. Investors should consider other tech stocks that have immense growth potential due to businesses focused on disruptive offerings like the cloud, digital payments, chipsets and crypto currencies including Facebook (FB), NVIDIA (NVDA), Advanced Micro Devices (AMD), and Square (SQ).
4 "Strong Buy" Tech Stocks That Will Continue to Dominate in 2021
The technology sector has been one of the strongest pillars of the stock market since March. Within the sector, chipmakers have skyrocketed and established their firm position and are poised to see greater highs due to the growth in computing, 5G, and other disruptive technologies. Taiwan Semiconductor (TSM), Qualcomm (QCOM), Broadcom (AVGO), and Applied Materials. (AMAT) are geared up for solid growth for the rest of the year and in 2021.
3 Under-the-Radar Ecommerce Stocks that are "Buy Rated"
E-commerce has been the savior for retailers amid the pandemic. These online portals have witnessed explosive growth in the past months, and they still have more room to grow. As the big players have gained significantly with continued investor attention, mid-sized players like MercadoLibre (MELI), Chewy (CHWY), and Revolve Group (RVLV) still offer upside.
3 "Buy Rated" International Tech Stocks to Invest In
As the technology sector continues to show immense growth potential based on innovative offerings, technology stocks continue to rise. But considering the weakness in the domestic economy, it might be a good idea to diversify to well-performing international tech stocks. Sea (SE), Johnson Controls (JCI), and Bilibili (BILI) are three such stocks that have the potential for strong upside over the long run.
Forget Lululemon, Buy These 3 Retail Stocks for the Upcoming Holiday Season
As we head into the holiday season, shoppers are likely to look for discounts and home goods. The demand for home décor, electronic gadgets, and home appliances should be massive. Stocks such as Best Buy (BBY), Five Below (FIVE), and Williams-Sonoma (WSM) could see substantial upside.
3 "Buy Rated" Healthcare ETFs to Buy for a Biden Presidency
The COVID-19 pandemic has brought the healthcare sector in focus like never before. With an imminent second wave and Biden’s goal to broaden health care coverage, various forms of healthcare services should see huge demand. The Health Care Select Sector SPDR Fund (XLV), iShares U.S. Healthcare Providers ETF (IHF), and Invesco DWA Healthcare Momentum ETF (PTH) are well-positioned to benefit in the upcoming months.
4 Stocks to Buy Before the Holiday Shopping Season
E-commerce has seen robust demand in the wake of the pandemic. With the holiday shopping season kick starting on Thanksgiving, people will head to e-commerce platforms in droves. This would should give a boost to companies like Amazon (AMZN), Alibaba (BABA), Etsy (ETSY), and Wayfair (W).
3 Biotech Stocks Set to Soar in 2021
As Pfizer (PFE) announced that its COVID-19 vaccine candidate is 90% effective, biotech stocks are on fire. These stocks have seen a bull-run since the beginning of 2020 and are expected to witness the same in 2021 as well. In addition to the boost from the pandemic, Jazz (JAZZ), Arrowhead (ARWR), United Therapeutics (UTHR), and Intellia (NTLA) can withstand any adverse situation.
Forget Facebook, Buy These 3 Mega-Cap Stocks Instead
With its revenue growth slowing for the past two quarters, FB braces for an uncertain 2021. The mega-cap company is also standing on the verge of a major antitrust lawsuit by the Federal Trade Commission. In the wake of this ambiguity, investors can seek other large-cap stocks that are on a higher growth trajectory such as Microsoft (MSFT), Amazon (AMZN), and Alphabet (GOOGL) are three such stocks that have flourished amid the pandemic and are positioned for further growth.